'sugar released'

GLIMP M 1/500MG TABLET is used to manage type 2 diabetes mellitus when diet, exercise and the single agent does not result in adequate glycemic control. It is a combination of Glimepiride and Metformin which belongs to a group of medicines called Antidiabetic agents. Glimepiride lowers blood sugar by causing the pancreas to produce more insulin and helps the body to use insulin efficiently. Metformin reduces the total amount of sugar released into the blood by the liver.

Glycitop 60mg Tablet MR is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.

Glycitop-MR 30 Tablet is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps prevent serious complications of diabetes.

Glycitop 60mg Tablet MR is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.

Glycitop 80mg Tablet is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.

To control blood sugar levels in adults with type 2 diabetes. The combination medication helps to lower blood sugar by targeting different mechanisms within the body.

Empagliflozin and metformin combination is used with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. It is also used to lower the risk of cardiovascular death in patients with type 2 diabetes and heart or blood vessel disease.

Empagliflozin 25mg and Linagliptin 5mg tablets (Glyxambi) are used to improve blood sugar control in adults with type 2 diabetes, often used alongside diet and exercise, and may also reduce the risk of death from heart problems in those with type 2 diabetes and cardiovascular disease.

Empagliflozin 10 mg and Linagliptin 5 mg tablets, sold as Glyxambi, are used to improve blood sugar control in adults with type 2 diabetes, often as an adjunct to diet and exercise, and can also help reduce the risk of cardiovascular death in those with existing heart disease